Latest severe allergic reactions Stories
OTTAWA, Aug. 29, 2012 /CNW/ - As children head back to the classroom, Health Canada is reminding parents of the importance of allergy awareness when packing lunches for their children. Severe allergic reactions can occur quickly and without warning, and some foods can be life-threatening to allergic children. It is estimated that as many as 1.2 million Canadians may be affected by allergies. Some studies indicate that these numbers are increasing, especially among children....
Pfizer Canada Inc. and WestJet offer suggestions for a safer and less stressful travel experience KIRKLAND, QC and CALGARY, AB, May 15, 2012 /CNW/ - Pfizer Canada Inc., makers of EpiPen(®) (epinephrine) Auto-Injector, and WestJet today announced results of a survey commissioned to determine the concerns of Canadians at risk of anaphylaxis who may be travelling this summer. A total of 666 Canadian adults, who were all prescreened as being at risk of anaphylaxis,(a) or as...
BASKING RIDGE, N.J., Dec. 23, 2010 /PRNewswire-FirstCall/ -- Dey Pharma, L.P. today announced that it has signed a license agreement with Meda, a leading international specialty pharma company headquartered in Sweden, for the exclusive marketing and distribution rights of EpiPen® (epinephrine) Auto-Injector in Europe. EpiPen Auto-Injector is used for emergency treatment of severe allergic reactions (anaphylaxis). Anaphylaxis can occur quickly, often within a couple of minutes, and may be...
GARDASIL(R) (Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant), the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26. These are the only data evaluating efficacy of any HPV vaccine in preventing disease in males, and were presented for the first time this week at the European Research Organization on...
